Dermal Fillers

Patients often come to me with a treatment already chosen: “I want filler.”

My first question is usually: filler for what?

That is not a technicality. “Filler” describes a material and a treatment category. It does not describe the anatomical problem.

A patient may be bothered by a hollow, a shadow, a weak contour, facial asymmetry, a deeper fold, an underprojected chin or a midface that looks different from a few years ago. Another patient may use exactly the same words but actually have tissue descent, skin laxity, swelling, skeletal proportions or simply enough volume in the wrong visual relationship.

These concerns can look similar in photographs. They are not the same mechanism.

So before discussing product, syringe number or injection point, I want to establish something more basic: what has changed, which tissue is responsible, and would adding volume actually improve it?

Filler is a material, not a diagnosis

Hyaluronic acid dermal fillers are injectable gels that can add or redistribute soft-tissue volume. Depending on the anatomy, they can be used to restore a selected deficiency, modify projection, soften a transition or create better proportional continuity between neighbouring regions of the face.

This makes filler versatile.

It also makes it easy to misuse.

If every hollow is interpreted as volume loss, every ageing change becomes a filler indication. If every soft jawline becomes a request for more projection, volume continues to accumulate. If every patient who says “I want a lift” receives more filler, a positional problem is gradually converted into a volumetric treatment.

I do not think that is a sustainable way to treat a face.

Before adding volume, I need to know why volume is missing — or whether it is missing at all.

The safest syringe is sometimes the one I decide not to use.

The same visible concern can come from very different mechanisms

One of the most important parts of filler assessment is separating what the patient sees from what is producing it.

This is why I do not like beginning with an injection map.

The map should be the consequence of the diagnosis.

What hyaluronic acid filler can actually do

At its core, filler adds volume.

Depending on where and how that volume is placed, the visual result can be very different. A small amount in a structurally useful area may improve projection. Another placement may soften a transition between two regions. In selected anatomy, restoring volume can change how light falls across the face and make a previously harsh shadow less visible.

These can be valuable changes.

But I also want to be precise about the boundaries.

• Filler does not remove fat.
• Filler does not fundamentally change the skeleton.
• Filler does not tighten significant skin laxity.
• Filler does not truly reposition descended tissue.
• Filler does not correct pigmentation or skin texture simply by adding volume.
• Filler cannot guarantee perfect facial symmetry.
• Filler cannot reproduce a fixed photographic template in a moving face.

When one of these other mechanisms dominates, a different treatment category may be more appropriate.

The fact that filler can be injected into an area does not mean filler is the correct answer for that area.

Why “lifting with filler” needs careful language

Patients often ask for filler because they want the face to look lifted.

I understand what they mean visually. A cheek may appear lower. The transition between the cheek and lower face may have changed. Shadows are different. A younger photograph may show more apparent support.

But I prefer to separate the visual request from the anatomical mechanism.

If volume loss is contributing to the change, restoring selected volume can improve support and light reflection. The face may look fresher, and the patient may reasonably describe that as a lifting effect.

That does not mean filler has repositioned the tissues.

When descent and laxity become dominant, repeatedly adding volume to imitate lift can eventually produce exactly the opposite of the intended result: a face that looks heavier.

Volume can support a transition. It cannot become a surgical lift simply because enough of it is added.

I think this distinction matters particularly in long-term filler treatment, because a small amount of camouflage can be useful while repeated camouflage can gradually change facial proportions.

The face should not be treated as a collection of empty spaces

Traditional filler language can encourage an area-by-area mentality: cheeks, temples, tear troughs, nasolabial folds, lips, chin, jawline.

Those areas are useful anatomical descriptions. They are not independent faces.

Adding volume in one region changes the visual relationship with the next.

A fuller cheek changes how the under-eye transition looks. More chin projection changes the relationship between the lips, jaw and neck. Lateral jawline augmentation changes lower-face width. Lip volume changes the balance of the central face.

This means I need to know not only what the filler will improve locally, but what that additional volume will do globally.

A face can contain several technically successful filler treatments and still become aesthetically incoherent when nobody has stepped back to assess the total volume.

For me, the face always has priority over the individual injection site.

Diagnosis matters more than the brand or product

Patients sometimes arrive having researched a specific filler brand or a particular product characteristic.

Product choice matters. Different fillers have different physical properties and are not interchangeable in every tissue plane or treatment objective.

But I do not think product should be the first decision.

If I have not yet decided whether volume should be added, choosing the ideal product for adding that volume is premature.

My sequence is different:

1. Define the concern.
2. Identify the dominant anatomical mechanism.
3. Decide whether additional volume is appropriate.
4. Decide which region and plane should carry that volume.
5. Then select the product characteristics and dose that match the plan.

Technique matters enormously, but technique should come after indication.

Why injection plane changes the result

Filler placed at different tissue depths does not behave in exactly the same way.

The face contains skin, superficial and deeper soft tissues, muscles, ligaments, vessels and bone. The appropriate depth depends on the treatment objective and the anatomy of the region.

This affects projection, integration, movement and how visible or palpable the product may become.

It is one reason I do not reduce filler treatment to “putting volume where the face looks empty”.

The same material can produce a different result depending on depth, distribution and dose.

And the smallest technical difference becomes more important in mobile or thin-tissue regions.

This is also why copying another patient’s injection map makes little sense to me. Their tissue thickness, skeletal support, movement pattern and previous treatments are not yours.

How I decide whether a patient is a good filler candidate

I first want a problem that filler can logically improve.

A selected contour deficiency, true volume loss or a transition that benefits from additional support may make sense.

Then I look at the cost of creating that improvement.

How much volume would be required? How full is the face already? How thick are the tissues? Is the patient prone to swelling? Is there previous filler? Is the requested endpoint subtle enough to remain compatible with the anatomy?

A theoretically correct indication can become a poor treatment if the amount required creates more heaviness than benefit.

I am therefore more cautious when:

• the face is already substantially volumised;
• tissue descent or skin laxity is the dominant problem;
• the patient has a strong tendency toward facial swelling;
• previous filler volume is uncertain;
• the requested change depends on copying another person’s facial architecture;
• a large amount of filler would be needed to camouflage a structural deficiency;
• the patient expects permanent or perfectly predictable symmetry.

Sometimes the conclusion is another filler plan.

Sometimes it is another treatment category.

Sometimes it is reduction of previous filler before considering anything new.

And sometimes the face simply does not need more volume.

How much filler is enough?

I do not think syringe count should drive the treatment.

It is a measurement of how much product is available. It is not a diagnosis.

The correct amount depends on how large the actual deficiency is and how much additional volume the surrounding anatomy can accept before the character of the face begins to change.

This is where conservative dosing becomes important.

If a smaller first treatment creates most of the useful improvement, I would rather stop and reassess than complete an arbitrary volume target.

If additional treatment remains useful after the tissues have settled, that decision can be made with better information.

I would rather leave a small question for the second appointment than create a large problem in the first.

Staged treatment is not simply about being cautious. It gives us control.

Why swelling tendency changes the plan

Not every patient’s soft tissue responds to filler in the same way.

Temporary swelling and bruising can occur after treatment. Some patients settle relatively quickly. Others retain fluid more noticeably or for longer.

This matters aesthetically as well as practically.

A patient who naturally becomes puffy around the midface may not be a good candidate for the same volume strategy as someone whose tissues tolerate additional volume with very little visible fluid retention.

It also affects expectations.

If a patient wants a razor-sharp contour that looks identical every morning, every evening and in every lighting condition, I need to explain that soft tissue does not behave that way.

Biology remains part of the result.

Reversibility does not make filler casual

One advantage of hyaluronic acid fillers is that, when appropriate, they can often be reduced using hyaluronidase.

That gives us an important corrective option.

I do not think it should change the standard of the initial decision.

“We can dissolve it later” is not a reason to inject something that does not have a clear indication today.

Reduction itself is another medical intervention. Previous anatomy may not be completely known. The distribution of filler may be complex, particularly after repeated treatments from different clinics or over several years.

Reversibility is useful because medicine sometimes requires correction.

It is not permission to plan carelessly.

When previous filler has started to look heavy

Revision filler is increasingly common, and I approach it differently from first-time treatment.

The patient may say, “I have lost definition, so I think I need more.”

But if substantial filler remains, the loss of definition may actually be the consequence of accumulated volume.

Adding more can then create a cycle:

one region looks heavy, so another region is augmented to restore proportion; that creates more total volume, which then requires further balancing elsewhere.

At some point the face is no longer being treated for the original anatomy. It is being treated for the consequences of previous filler.

An overfilled face is usually not corrected by finding another place to add filler.

I first want to reassess.

Where is the existing volume? How much of the appearance may be swelling? Which areas are genuinely deficient and which only look deficient because neighbouring areas have become too full?

Depending on the answer, the treatment may involve waiting, reduction when appropriate, limited rebuilding or no further augmentation.

The objective in revision is not to produce another dramatic change. It is to recover proportion.

Maintenance should not mean automatic refilling

Dermal fillers are temporary, but their behaviour over time is variable.

Product, treatment region, dose, metabolism, tissue characteristics and previous procedures all influence longevity.

For that reason, I avoid treating maintenance as a fixed calendar event.

If a patient returns because twelve months have passed, I do not automatically assume that the original volume should be replaced.

I want to know what remains and what has changed.

Does the area still look balanced? Is there residual filler? Has ageing changed a neighbouring structure? Has body weight changed? Has the patient’s objective changed?

The correct treatment today may be smaller than before. It may be different. It may be unnecessary.

A maintenance programme that never reassesses the face eventually becomes an accumulation programme.

What should a good filler result look like?

I do not think a good result should primarily make the patient look “filled”.

I look for improved relationships.

A transition is smoother. A deficient point has enough projection. A shadow is less abrupt. Facial proportions make more sense from more than one angle.

Most importantly, the treatment should still belong to that patient’s face.

I am cautious about template-based endpoints because facial identity is partly created by individual variation. Not everybody should have the same cheek projection, the same lips, the same chin or the same jawline width.

Aesthetic medicine becomes less convincing when every face begins moving toward the same geometry.

My goal is not to replace variation with a template.

It is to decide whether one specific anatomical relationship can be improved without losing the relationships that already work.

Safety is both technical and diagnostic

Dermal filler treatment is a medical procedure.

Bruising, swelling, tenderness, asymmetry, palpable or visible irregularities and nodules can occur. Fillers also carry uncommon but potentially serious vascular complications.

For that reason, anatomical knowledge, appropriate injection technique, product selection, sterile practice, complication recognition and access to appropriate management are important.

But I also separate safety into two levels.

Technical safety: can the treatment be performed appropriately?

Decision safety: should this treatment be performed at all?

You can perform an injection technically well and still create a poor outcome if the original diagnosis was wrong.

• Adding volume to a face that is already full can create heaviness.
• Treating tissue descent as volume loss can lead to progressive overfilling.
• Trying to correct a substantial skeletal limitation with soft tissue can create disproportion.
• Repeatedly treating early swelling as undercorrection can create unnecessary accumulation.
• Trying to reproduce a filtered reference can push treatment beyond the patient’s natural anatomy.

For me, correct indication is part of safety.

The questions I want answered before I recommend filler

Before I recommend hyaluronic acid filler, I want to be able to answer several questions clearly:

• What exactly is bothering the patient?
• Has something objectively changed, or are we responding mainly to a reference image or trend?
• Which anatomical structure is producing the visible concern?
• Is the problem genuinely related to insufficient volume?
• Would adding volume improve the relationship between the surrounding structures?
• How much volume already exists?
• Is there previous filler that needs to be understood first?
• How likely is the tissue to swell or retain fluid?
• Can the requested result be achieved without making another part of the face heavier?
• Are we asking filler to perform the job of surgery, skin treatment or another procedure?
• Would a smaller, staged treatment give better control?
• Would another treatment category address the mechanism more directly?
• Would doing nothing currently have the better benefit–trade-off balance?

Only after those questions are answered does product, plane and dose become the main conversation.

Hyaluronic acid filler can be an extremely useful tool. It is adjustable, versatile and capable of producing very subtle changes when the indication is correct.

But its versatility is exactly why judgment matters.

I do not want to use filler simply because a region can accept filler. I want to use it when additional volume is the simplest and most coherent way to solve a clearly defined anatomical problem.

The goal is not to fill the face.

The goal is to understand where volume helps, where it does not, and where the correct amount is zero.

Frequently asked questions

How do I know whether dermal filler is appropriate for me?

I first need to understand the mechanism behind the concern. A genuine volume deficiency, mild projection problem or selected transition may respond well to filler. If the dominant issue is skin laxity, tissue descent, excess soft tissue, pigmentation or a substantial skeletal limitation, another treatment may address the problem more directly.

Can fillers replace surgery?

Sometimes filler can camouflage a modest contour or volume issue, but filler and surgery work through different mechanisms. Filler adds soft-tissue volume. Surgery can reposition, remove or structurally alter tissues depending on the procedure. When descent, significant laxity or a larger structural deficiency dominates, increasing filler volume is not the same as correcting that mechanism.

Can filler really lift the face?

Restoring selected volume can improve support and soften transitions, so the overall face may appear more lifted. Anatomically, however, filler adds volume rather than truly repositioning descended tissue. I prefer to make that distinction clear before deciding whether filler is appropriate.

How much filler do I need?

There is no universal syringe number. The amount should follow the anatomical deficiency, existing facial volume, tissue characteristics and the change that can be achieved without introducing unnecessary heaviness. When there is uncertainty, I generally prefer conservative treatment and reassessment.

Will filler make my face look puffy?

It can. Excessive volume, inappropriate distribution, an already-full face and individual swelling tendency can all contribute to puffiness or heaviness. This is one reason I assess both existing volume and tissue behaviour before adding more.

How long do fillers last?

Duration varies according to the product, treatment area, amount, tissue characteristics, metabolism and previous treatment history. I do not think a fixed duration should automatically determine maintenance. The face should be reassessed before more product is added.

Can hyaluronic acid filler be dissolved?

Hyaluronic acid filler can often be reduced with hyaluronidase when clinically appropriate. This is a useful corrective option, but it does not make filler treatment risk-free or make careful initial planning unnecessary.

What are the main risks?

Possible problems include swelling, bruising, tenderness, asymmetry, contour irregularity and nodules. Less common but potentially serious vascular complications can also occur. Appropriate indication, anatomical knowledge, technique, safety protocols and follow-up are therefore essential parts of treatment.

What if I already have a lot of filler?

I would first assess what is present before discussing additional volume. A region can look deficient because another region has become overfilled, and adding more may worsen the imbalance. Depending on the findings, waiting, reduction when appropriate or conservative rebuilding may be more logical than further augmentation.

Why do you sometimes recommend treating only one area?

Because the face is interconnected. Correcting the dominant deficiency may improve neighbouring relationships without treating every visible concern separately. I prefer the smallest coherent treatment plan rather than assuming that every area mentioned during consultation needs an injection.

Should filler maintenance be done every year?

Not automatically. Maintenance should begin with reassessment of the current anatomy and existing volume. If adequate volume remains or the face is already balanced, there may be nothing useful to replace simply because a certain amount of time has passed.

What does a natural filler result mean to you?

It means the treatment improves a specific anatomical relationship without becoming the dominant feature of the face. The patient should still look recognisably like themselves, and the result should remain coherent from different angles and during normal expression rather than only in a selected photograph.

When would you recommend against filler?

I would be cautious when additional volume does not address the dominant mechanism, when the face is already heavily volumised, when laxity or tissue descent is the main concern, when previous filler needs to be reassessed first, or when the requested endpoint depends on reproducing another person’s or a filtered face. Sometimes another treatment makes more sense. Sometimes reduction makes more sense. And sometimes the correct decision is simply not to add volume.